Quadrivia AI Aims to Automate Routine Clinical Coordination at Scale
Quadrivia AI, founded by Dr. Ali Parsa in late 2023 and launched in late 2024, is developing an enterprise AI platform called Q for clinical operations. Its Clinical Process Outsourcing model pairs autonomous software agents with oversight from licensed clinicians to manage high-volume coordination tasks. The system is designed to support intake, scheduling, referrals, discharge planning, care coordination, medication adherence, and EHR documentation while expanding clinical workforce capacity rather than replacing human decision-makers.
Quadrivia AI was founded in late 2023 by Dr. Ali Parsa and launched in late 2024. Its enterprise platform, Q (also called Qu in early filings), is positioned as neither a conversational bot nor a standard intake questionnaire nor an automated telephone menu. Instead, it uses a Clinical Process Outsourcing model: autonomous software agents work alongside licensed clinicians who provide oversight.
The company targets routine, high-volume coordination: patient intake, scheduling, specialist referrals, discharge planning, care coordination, medication adherence, and EHR documentation. Parsa previously founded Circle Health and Babylon Health. Quadrivia says Q is meant to increase clinical workforce capacity, leaving complex diagnostic decisions to human clinicians.
If deployed as intended, systems like Q could speed scheduling, referrals, discharge planning, and medication follow-up, potentially improving access for patients and reducing administrative load on clinicians. That may ease burnout and expand capacity in strained health systems. Yet automation in clinical coordination may also raise concerns about errors, accountability, and whether human oversight remains meaningful. The scale of impact could depend on regulation, integration with existing records, and how carefully licensed clinicians supervise routine workflows.